[1]Chen H, Fre S, Slepnev VI, et al. Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis[J]. Nature, 1998,394(6695):793-797.
[2]McMahon HT, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis[J]. Nat Rev Mol Cell Biol, 2011,12(8):517-533.
[3]Horvath CA, Vanden Broeck D, Boulet GA, et al. Epsin: inducing membrane curvature[J]. Int J Biochem Cell Biol, 2007,39(10):1765-1770.
[4]Ko G, Paradise S, Chen H, et al. Selective high-level expression of epsin 3 in gastric parietal cells, where it is localized at endocytic sites of apical canaliculi[J]. Proc Natl Acad Sci U S A, 2010,107(50):21511-21516.
[5]Spradling KD, McDaniel AE, Lohi J, et al. Epsin 3 is a novel extracellular matrix-induced transcript specific to wounded epithelia[J]. J Biol Chem, 2001,276(31):2925729267.
[6]Chang B, Tessneer KL, McManus J, et al. Epsin is required for Dishevelled stability and Wnt signalling activation in colon cancer development[J]. Nat Commun, 2015,6:6380.
[7]Coon BG, Direnzo DM, Konieczny SF, et al. Epsins’ novel role in cancer cell invasion[J]. Commun Integr Biol, 2011,4(1):95-97.
[8]Schiano Lomoriello I, Giangreco G, Iavarone C, et al. A self-sustaining endocytic-based loop promotes breast cancer plasticity leading to aggressiveness and pro-metastatic behavior[J]. Nat Commun, 2020,11(1):3020.
[9]Mauri G, Sartore-Bianchi A, Russo AG, et al. Early-onset colorectal cancer in young individuals[J]. Mol Oncol, 2019,13(2):109-131.
[10]Liu ShH, Wang W, Mu XS. Expression of Golgi phosphoprotein 3 in colorectal cancertissues and its effects on proliferation,invasion andmigration of colorectal cancer cells[J]. Acta Anatomica Sinica, 2018, 49(4):461-468.(in Chinese)
刘师宏, 汪威, 穆小松. 高尔基体磷蛋白3在结直肠癌组织中表达及其对结直肠癌细胞增殖、侵袭和迁移的影响[J]. 解剖学报, 2018,49(4):461-468.
[11]Piawah S, Venook AP. Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer[J]. Cancer, 2019,125(23):4139-4147.
[12]Wang Y, Song W, Kan P, et al. Overexpression of Epsin 3 enhances migration and invasion of glioma cells by inducing epithelialmesenchymal transition[J]. Oncol Rep, 2018,40(5):3049-3059.
[13]Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators[J]. Trends Biochem Sci, 2006,31(2):89-97.
[14]Stranger BE, Forrest MS, Dunning M, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes[J]. Science, 2007,315(5813):848-653.
[15]Polo S, Pece S, Di Fiore PP. Endocytosis and cancer[J]. Curr Opin Cell Biol, 2004,16(2):156-161.
[16]Mosesson Y, Mills GB, Yarden Y. Derailed endocytosis: an emerging feature of cancer[J]. Nat Rev Cancer, 2008,8(11):835-850.
[17]Song K, Cai X, Dong Y, et al. Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development[J]. J Clin Invest, 2021,131(1): e129374.
[18]Dong Y, Wu H, Rahman HN, et al. Motif mimetic of epsin perturbs tumor growth and metastasis[J]. J Clin Invest, 2015,125(12):4349-4364.
|